Leading prescription drugs South Korea 2019, by production value

Published by Statista Research Department, Dec 14, 2022
In 2019, the anti-inflammatory medicine Remsima had a production value of around 108.7 billion South Korean won in South Korea. This made it the leading prescription drug within the country that year in terms of production. Remsima is an injection that can be used to treat rheumatoid arthritis.

Leading prescription pharmaceutical drugs in South Korea in 2019, by production value (in billion South Korean won)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

October 2021

Region

South Korea

Survey time period

2019

Supplementary notes

1,000 South Korean won equals 0.83 U.S. dollars or 0.74 euros as of March 2022.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the Asia-Pacific regionPharmaceutical industry in JapanPharmaceutical industry in ChinaPharmaceutical industry in AustraliaState of health in the Asia-Pacific region
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu